Bylaws

STATUTE [Spanish]

 

DENOMINACIÓN, DOMICILIO y OBJETO SOCIAL

 

Artículo 1
Con la denominación de SOLACI, SOCIEDAD LATINOAMERICANA DE CARDIOLOGÍA INTERVENCIONISTA, ASOCIACIÓN CIVIL, continúa funcionando la asociación civil constituida bajo la denominación de “Sociedad Latinoamericana de Cardiología Intervencionista, Asociación Civil” el día 7 del mes de diciembre de 1999, una entidad sin fines de lucro, con domicilio en la ciudad de Buenos Aires.

 

Artículo 2
Son sus propósitos procurar la excelencia en el ejercicio de la cardiología intervencionista a través de la formación y entrenamiento de profesionales, promocionando la investigación y desarrollando estándares y lineamientos generales conducentes a una adecuada política del cuidado de la salud humana, en especial en nuestro país y Latinoamérica, atendiendo a las particularidades de la región. Su objeto se cumplirá resguardando en todo momento una relación ética entre la investigación científica y la industria productora de tecnología y medicamentos.

Previous article
Next article

More articles by this author

Download the Official SOLACI-CACI 2024 Congress APP

  DOWNLOAD THE OFFICIAL APP OF SOLACI-CACI 2024 Next Wednesday marks the beginning of SOLACI-CACI 2024! Download the Congress APP and discover the unmissable program of the...

Survey on Hemodynamics Centers in Latin America – SOLACI, Stent Save a Life! and South American Society of Cardiology Initiative

The treatment of ST-segment elevation myocardial infarction (STEMI) in Latin America is highly diverse. There are notable differences between countries and even among regions...

SOLACI-SBHCI 2023 Congress Has Begun!

Let the best begin! After a year of intense work, SOLACI-SBHCI 2023 Congress—the widest, most important event for interventional cardiologists in Latin America—has kicked...

SOLACI-SBHCI 2023 Congress Has Begun!

Let the best begin! After a year of intense work, SOLACI-SBHCI 2023 Congress—the widest, most important event for interventional cardiologists in Latin America—has kicked...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

TricValve is the first bicaval valve system to obtain CE-Mark approval. This device heterotopic device eliminates tricuspid insufficiency reflux into the venous system, reducing...

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...